8-K: SCWorx Corp. Secures $1.155 Million Through Convertible Note Offering

SCWorx Corp. has entered into a securities purchase agreement to sell senior secured convertible notes and warrants for gross proceeds of $1.155 million.

Summary

• SCWorx Corp. has secured $1.155 million through a securities purchase agreement.
• The agreement involves the sale of senior secured convertible notes with an aggregate principal amount of $1.155 million.
• The initial conversion price for the notes is $1.43 per share.
• The offering also includes Series A, B, and C warrants to acquire up to 4,846,158 additional shares of common stock.
• The Series A warrants are exercisable at $1.43 per share, while Series B and C warrants are exercisable at $1.573 per share.
• The warrants are exercisable immediately and expire five years from the date of issuance.
• The gross proceeds are expected to be $1.155 million, including $825,000 in cash and the exchange of a $330,000 secured promissory note.
• The company intends to use the proceeds for operating expenses and general working capital.
• The convertible notes mature on the earlier of January 15, 2025, under certain conditions, or December 31, 2025.
• Principal payments on the notes will begin 30 days after the effective date of a registration statement or 60 days after certain financial reports are filed.
• Amortization payments can be made in cash or common stock, subject to certain limitations.
• The notes accrue interest at 10% per annum, compounding, payable quarterly in cash or shares at the company's option.
• Upon an Event of Default, the interest rate increases to 18% per annum.
• The conversion price is subject to full ratchet anti-dilution adjustments.
• The company has agreed to seek stockholder approval for the issuance of more than 19.9% of its outstanding shares by September 12, 2024.
• The notes are secured by a first priority security interest in substantially all of the company's assets.
• The Series B warrants are subject to a call option by the company under certain trading conditions.
• The company is required to file a resale registration statement for the shares issuable upon conversion of the notes and exercise of the warrants.
• The company is also settling a $502,000 arbitration award by issuing shares of common stock to the vendor.

Sentiment

Score: 4

Explanation: The document indicates a necessary but potentially dilutive financing event. While the company secures needed capital, the terms of the offering, particularly the anti-dilution provisions and security interest, present risks for existing shareholders. The delays in filing financial reports also raise concerns.

Positives

• The company has successfully secured a significant amount of funding.
• The convertible notes provide flexibility in repayment options, including cash or shares.
• The warrants offer potential for additional capital if exercised.
• The company is addressing a significant arbitration award by issuing shares.

Negatives

• The notes are secured by a first priority security interest in substantially all of the company's assets, which could be a concern for existing shareholders.
• The conversion price is subject to full ratchet anti-dilution adjustments, which could lead to significant dilution.
• The company is obligated to seek stockholder approval for the issuance of more than 19.9% of its outstanding shares, which may not be guaranteed.
• The notes have a relatively short maturity date of December 31, 2025, or potentially earlier if certain conditions are not met.

Risks

• The company's ability to settle conversions and make payments using shares is limited until stockholder approval is obtained.
• The full ratchet anti-dilution adjustment on the conversion price and warrant exercise price could significantly dilute existing shareholders.
• The company is subject to certain covenants that restrict its ability to incur debt, make acquisitions, and transfer assets.
• Failure to file required financial reports or comply with Nasdaq listing standards could trigger an earlier maturity date for the notes.
• The company may be obligated to issue additional shares of common stock to the vendor to satisfy the arbitration award.

Future Outlook

The company expects to use the proceeds from the offering to fund operating expenses and for general working capital.

Industry Context

This type of financing is common for companies seeking to raise capital, particularly those that may not have access to traditional bank loans or equity markets. The use of convertible notes and warrants can be attractive to investors seeking potential upside from both debt and equity.

Comparison to Industry Standards

• The use of convertible notes and warrants is a common financing method for small-cap and micro-cap companies, particularly in the biotech and technology sectors.
• The interest rate of 10% on the convertible notes is relatively high, reflecting the risk associated with investing in a company like SCWorx.
• The full ratchet anti-dilution protection is a strong protection for investors, but it can be very dilutive to existing shareholders.
• The inclusion of warrants is a common practice to incentivize investors to participate in the offering.
• The requirement for stockholder approval for the issuance of more than 19.9% of outstanding shares is a standard provision to protect existing shareholders from excessive dilution.
• The first priority security interest in substantially all of the company's assets is a common feature in secured debt financings.

Legal Proceedings

• The company is settling a $502,000 arbitration award by issuing shares of common stock to the vendor.

Stakeholder Impact

• Shareholders may experience dilution due to the conversion of notes and exercise of warrants.
• Creditors may benefit from the first priority security interest in the company's assets.
• Employees may benefit from the company's ability to fund operating expenses and working capital.
• Customers and suppliers may be impacted by the company's ability to continue operations.

Next Steps

• The company needs to file a resale registration statement for the shares issuable upon conversion of the notes and exercise of the warrants.
• The company needs to seek stockholder approval for the issuance of more than 19.9% of its outstanding shares by September 12, 2024.
• The company needs to complete the settlement of the arbitration award by issuing shares of common stock to the vendor.

Key Dates

Keywords

convertible notes, warrants, securities purchase agreement, common stock, financing, dilution, capital raise, operating expenses, working capital, arbitration award